Sanofi to cut 1,700 jobs in U.S. pharma sector
Sanofi-Aventis plans to cut 25 percent of its U.S. pharmaceutical operations workforce in a restructuring plan, which will result in a loss of almost 1,700 positions.

The Paris-based company said the decisions will be finalized in mid-December, and the move will allow the company to better focus on the areas of diabetes, atrial fibrillation and oncology.

"This step in our transformation strategy will expedite decision making, reduce business complexities and increase innovation, ensuring we rapidly respond to patient and customer needs," said Gregory Irace, president and CEO of Sanofi-Aventis U.S./Canada pharmaceutical operations.

Currently, 6,900 people are employed within the company’s pharmaceutical operations division.

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Trimed Popup
Trimed Popup